Glory Health Industry Limited (2329.HK)
HKD 0.09
(-10.1%)
HKD 0.09
(-10.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.5 Billion | 3.9 Billion | 9.89 Billion | 5.76 Billion | 8.09 Billion | 6.61 Billion |
| Cost of Revenue | 2.55 Billion | 3.79 Billion | 8.65 Billion | 4.78 Billion | 5.95 Billion | 4.01 Billion |
| Gross Profit | -50.28 Million | 113.51 Million | 1.24 Billion | 980.32 Million | 2.13 Billion | 2.59 Billion |
| Operating Expenses | -50.28 Million | 826.53 Million | 290.59 Million | 99.24 Million | 132.65 Million | 121.76 Million |
| Selling, General and Administrative Expenses | 429.87 Million | 528.65 Million | 751.21 Million | 741.21 Million | 863.21 Million | 714.61 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -480.15 Million | 66.71 Million | 68.72 Million | 73.02 Million | 39.07 Million | 10.65 Million |
| Cost and Expenses | 2.98 Billion | 4.61 Billion | 8.94 Billion | 4.88 Billion | 6.08 Billion | 4.13 Billion |
| Operating Income | -484.56 Million | -415.13 Million | 496.01 Million | 239.1 Million | 1.27 Billion | 1.88 Billion |
| Interest Expense | 449.26 Million | 451.58 Million | 744.9 Million | 487.31 Million | 354.94 Million | - |
| Income Tax Expense | -85.11 Million | 95.05 Million | 532.35 Million | 383.07 Million | 826.55 Million | 1.12 Billion |
| Earnings before Tax | -678.62 Million | -1.09 Billion | 876.86 Million | 516.72 Million | 2.04 Billion | 2.69 Billion |
| Net Income | -563.97 Million | -912.78 Million | 228.33 Million | 98.74 Million | 859.76 Million | 1 Billion |
| Earnings Per Share Basic | -0.13 | -0.21 | 0.05 | 0.02 | 0.19 | 0.23 |
| Earnings Per Share Diluted | -0.13 | -0.21 | 0.05 | 0.02 | 0.19 | 0.23 |
| Weighted Average Shares Outstanding | 4.44 Billion | 4.34 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.46 Billion |
| Gross Margin | -0.02 | 0.03 | 0.13 | 0.17 | 0.26 | 0.39 |
| EBIT Margin | -0.06 | -0.08 | 0.06 | 0.06 | 0.17 | 0.30 |
| Profit Margin | -0.23 | -0.23 | 0.02 | 0.02 | 0.11 | 0.15 |
| EBITDA | -145.85 Million | -325.93 Million | 581.54 Million | 1.09 Billion | 1.35 Billion | 1.95 Billion |
| Earnings Before Tax Margin | -0.19 | -0.11 | 0.05 | 0.04 | 0.16 | 0.29 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Billion | 2.5 Billion | 1.45 Billion | 3.9 Billion | 958.4 Million | 2.94 Billion |
| Cost of Revenue | 1.27 Billion | 2.55 Billion | 1.27 Billion | 3.79 Billion | 668.57 Million | 3.12 Billion |
| Gross Profit | -230.43 Million | -50.28 Million | 180.15 Million | 113.51 Million | 289.83 Million | -176.31 Million |
| Operating Expenses | 180.25 Million | 429.87 Million | 432.88 Million | 826.53 Million | 298.72 Million | 527.81 Million |
| Selling, General and Administrative Expenses | 168.28 Million | - | 266 Million | - | 226.32 Million | 302.33 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 56.52 Million | - | 66.71 Million | - | - |
| Cost and Expenses | 1.46 Billion | 2.98 Billion | 1.7 Billion | 4.61 Billion | 967.29 Million | 3.65 Billion |
| Operating Income | -398.71 Million | -484.56 Million | -85.85 Million | -415.13 Million | 63.51 Million | -478.64 Million |
| Interest Expense | - | 449.26 Million | - | 451.58 Million | - | - |
| Income Tax Expense | 69.66 Million | -85.11 Million | 15.44 Million | 95.05 Million | 18.15 Million | 76.9 Million |
| Earnings before Tax | -393.35 Million | -678.62 Million | -285.26 Million | -1.09 Billion | -235.61 Million | -854.72 Million |
| Net Income | -297.09 Million | -563.97 Million | -266.87 Million | -912.78 Million | -230.29 Million | -682.48 Million |
| Earnings Per Share Basic | -0.07 | - | -0.06 | - | -0.06 | -0.15 |
| Earnings Per Share Diluted | -0.07 | - | -0.06 | - | -0.05 | -0.15 |
| Weighted Average Shares Outstanding | 4.24 Billion | 4.44 Billion | 4.44 Billion | 4.34 Billion | 4.11 Billion | 4.43 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion | 4.44 Billion |
| Gross Margin | -0.22 | -0.02 | 0.12 | 0.03 | 0.30 | -0.06 |
| EBIT Margin | -0.34 | - | -0.03 | - | 0.13 | -0.15 |
| Profit Margin | -0.28 | -0.23 | -0.18 | -0.23 | -0.24 | -0.23 |
| EBITDA | -357.63 Million | - | -50.35 Million | - | 121.87 Million | -447.8 Million |
| Earnings Before Tax Margin | -0.38 | -0.19 | -0.06 | -0.11 | 0.07 | -0.16 |
1416
CHVKY
002379
CAUUF
LMAT
KENDR